Revance Therapeutics Net Worth 2012-2019 | RVNC

Interactive chart of historical net worth (market cap) for Revance Therapeutics (RVNC) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Revance Therapeutics net worth as of September 20, 2019 is $0.63B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.634B $0.004B
Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance's science is based upon a proprietary TransMTS? peptide technology, which when combined with active drug molecules, may help address current unmet needs. Revance's initial focus is on developing daxibotulinumtoxinA, the company's highly purified botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company's lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines and cervical dystonia and has the potential to be the first long-acting neurotoxin. The company holds worldwide rights for all indications of RT002 injectable and RT001 topical and the pharmaceutical uses of the TransMTS technology platform.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $118.105B 13.45
Gilead Sciences (GILD) United States $84.118B 10.33
CSL (CSLLY) Australia $72.183B 0.00
Celgene (CELG) United States $70.428B 10.90
Vertex Pharmaceuticals (VRTX) United States $45.783B 49.48
Illumina (ILMN) United States $45.507B 53.47
Biogen (BIIB) United States $44.044B 7.82
Regeneron Pharmaceuticals (REGN) United States $32.496B 14.75
Alexion Pharmaceuticals (ALXN) United States $23.840B 12.57
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $17.466B 51.40
Exact Sciences (EXAS) United States $13.463B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.451B 0.00
Genmab (GNMSF) Denmark $12.585B 70.59
Seattle Genetics (SGEN) United States $11.969B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.212B 54.74
Alnylam Pharmaceuticals (ALNY) United States $9.619B 0.00
Galapagos (GLPG) Belgium $8.830B 0.00
Bio-Techne Corp (TECH) United States $7.595B 52.47
QIAGEN (QGEN) Netherlands $7.593B 24.94
Guardant Health (GH) United States $6.873B 0.00
BeiGene (BGNE) Cayman Islands $6.435B 0.00
Sarepta Therapeutics (SRPT) United States $6.134B 0.00
Amarin (AMRN) Ireland $6.015B 0.00
Moderna (MRNA) United States $5.966B 0.00
Exelixis (EXEL) United States $5.925B 15.40
Bluebird Bio (BLUE) United States $5.903B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.886B 0.00
Horizon Pharma Public (HZNP) Ireland $5.084B 12.92
ARGENX SE-ADR (ARGX) Netherlands $4.778B 0.00
Ascendis Pharma (ASND) Denmark $4.613B 0.00
China Biologic Products (CBPO) China $4.495B 28.06
Repligen (RGEN) United States $4.215B 81.79
Blueprint Medicines (BPMC) United States $3.973B 0.00
Spark Therapeutics (ONCE) United States $3.939B 0.00
Medicines (MDCO) United States $3.897B 0.00
MorphoSys AG (MOR) Germany $3.695B 0.00
Mirati Therapeutics (MRTX) United States $3.672B 0.00
Alkermes (ALKS) Ireland $3.331B 0.00
Immunomedics (IMMU) United States $3.185B 0.00
Reata Pharmaceuticals (RETA) United States $2.842B 0.00
MyoKardia (MYOK) United States $2.828B 0.00
Genomic Health (GHDX) United States $2.646B 49.63
CRISPR Therapeutics AG (CRSP) Switzerland $2.642B 0.00
Emergent Biosolutions (EBS) United States $2.635B 39.58
Arena Pharmaceuticals (ARNA) United States $2.545B 5.47
Ultragenyx Pharmaceutical (RARE) United States $2.456B 0.00
Amicus Therapeutics (FOLD) United States $2.406B 0.00
Halozyme Therapeutics (HALO) United States $2.395B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.285B 0.00
Acceleron Pharma (XLRN) United States $2.271B 0.00
NeoGenomics (NEO) United States $2.268B 121.33
Akcea Therapeutics (AKCA) United States $2.090B 0.00
Zai Lab (ZLAB) China $2.023B 0.00
Myriad Genetics (MYGN) United States $2.017B 21.16
Cambrex (CBM) United States $2.008B 25.39
Ligand Pharmaceuticals (LGND) United States $1.977B 25.00
UniQure (QURE) Netherlands $1.760B 0.00
Insmed (INSM) United States $1.747B 0.00
Denali Therapeutics (DNLI) United States $1.735B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.614B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.559B 0.00
Coherus BioSciences (CHRS) United States $1.517B 0.00
REGENXBIO (RGNX) United States $1.469B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.437B 0.00
Alector (ALEC) United States $1.371B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.321B 0.00
Editas Medicine (EDIT) United States $1.237B 0.00
Sangamo Therapeutics (SGMO) United States $1.233B 0.00
RA PHARMCTL INC (RARX) United States $1.202B 0.00
Fate Therapeutics (FATE) United States $1.190B 0.00
Innoviva (INVA) United States $1.117B 3.23
AnaptysBio (ANAB) United States $1.115B 0.00
Athenex (ATNX) United States $1.100B 0.00
Zymeworks (ZYME) Canada $1.077B 0.00
Epizyme (EPZM) United States $1.007B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.993B 0.00
Twist Bioscience (TWST) United States $0.912B 0.00
Cara Therapeutics (CARA) United States $0.887B 0.00
ANI Pharmaceuticals (ANIP) United States $0.876B 14.63
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.870B 0.00
WAVE Life Sciences (WVE) Singapore $0.852B 0.00
Pharming Group (PHGUF) Netherlands $0.831B 0.00
Arvinas (ARVN) United States $0.826B 0.00
Principia Biopharma (PRNB) United States $0.815B 425.13
Zealand Pharma (ZEAL) Denmark $0.765B 8.87
Cytokineticsorporated (CYTK) United States $0.763B 0.00
Anika Therapeutics (ANIK) United States $0.732B 25.91
UROGEN PHARMA (URGN) United States $0.728B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vericel (VCEL) United States $0.709B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.707B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.704B 25.40
Intellia Therapeutics (NTLA) United States $0.701B 0.00
Mesoblast (MESO) Australia $0.676B 0.00
MiMedx (MDXG) United States $0.592B 0.00
DBV Technologies S.A (DBVT) France $0.571B 0.00
Heska (HSKA) United States $0.567B 73.50
Retrophin (RTRX) United States $0.539B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.532B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.526B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.522B 0.00
Cellectis S.A (CLLS) France $0.491B 0.00
Stemline Therapeutics (STML) United States $0.490B 0.00
Precision BioSciences (DTIL) United States $0.489B 0.00
Syros Pharmaceuticals (SYRS) United States $0.475B 0.00
Intra-Cellular Therapies (ITCI) United States $0.471B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.455B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.444B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.440B 0.00
Puma Biotechnology (PBYI) United States $0.421B 0.00
Agenus (AGEN) United States $0.416B 0.00
Adverum Biotechnologies (ADVM) United States $0.415B 0.00
BioDelivery Sciences (BDSI) United States $0.412B 0.00
Bellus Health (BLU) Canada $0.411B 0.00
CytomX Therapeutics (CTMX) United States $0.408B 0.00
Arcus Biosciences (RCUS) United States $0.403B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.378B 0.00
Kadmon Holdings (KDMN) United States $0.364B 0.00
AC Immune SA (ACIU) Switzerland $0.364B 26.95
Protagonist Therapeutics (PTGX) United States $0.363B 0.00
Gritstone Oncology (GRTS) United States $0.346B 0.00
Theratechnologies (THERF) Canada $0.336B 0.00
Avid Bioservices (CDMO) United States $0.335B 0.00
Prothena (PRTA) Ireland $0.334B 0.00
Scholar Rock Holding (SRRK) United States $0.330B 0.00
ADMA Biologics Inc (ADMA) United States $0.316B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
Sorrento Therapeutics (SRNE) United States $0.299B 0.00
Dynavax Technologies (DVAX) United States $0.298B 0.00
Albireo Pharma (ALBO) United States $0.298B 0.00
Kindred Biosciences (KIN) United States $0.296B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.285B 0.00
Seres Therapeutics (MCRB) United States $0.280B 0.00
Cellular Biomedicine (CBMG) United States $0.276B 0.00
Geron (GERN) United States $0.269B 0.00
Clovis Oncology (CLVS) United States $0.259B 0.00
MannKind (MNKD) United States $0.250B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.250B 0.00
PDL BioPharma (PDLI) United States $0.247B 6.35
Prometic Life Sciences (PFSCF) Canada $0.246B 0.00
Senesco Technologies (ELOX) United States $0.246B 0.00
Inovio Pharmaceuticals (INO) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.243B 0.00
ChromaDex (CDXC) United States $0.243B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
EXICURE INC (XCUR) United States $0.236B 0.00
Compugen (CGEN) Israel $0.230B 0.00
Athersys (ATHX) United States $0.220B 0.00
Spero Therapeutics (SPRO) United States $0.220B 0.00
Affimed (AFMD) Germany $0.214B 0.00
Kamada (KMDA) Israel $0.208B 7.94
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Cue Biopharma (CUE) United States $0.198B 0.00
Five Prime Therapeutics (FPRX) United States $0.192B 0.00
OSMOTICA PHARM (OSMT) United States $0.191B 0.00
Alcobra (ARCT) United States $0.189B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.185B 0.00
XOMA (XOMA) United States $0.175B 0.00
Arsanis (XFOR) United States $0.174B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.168B 0.00
Acorda Therapeutics (ACOR) United States $0.168B 0.00
Enzo Biochem (ENZ) United States $0.167B 0.00
Dyadic (DYAI) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Abeona Therapeutics (ABEO) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.157B 0.00
Novavax (NVAX) United States $0.157B 0.00
Strongbridge Biopharma (SBBP) United States $0.145B 5.96
Paratek Pharmaceuticals (PRTK) United States $0.145B 0.00
Cerecor (CERC) United States $0.145B 0.00
Northwest Biotherapeutics (NWBO) United States $0.143B 0.00
Adocia (ADOCY) France $0.140B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.138B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Aptinyx (APTX) United States $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
NantKwest (NK) United States $0.127B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Menlo Therapeutics (MNLO) United States $0.114B 0.00
Fortress Biotech (FBIO) United States $0.112B 0.00
Vaccinex (VCNX) United States $0.109B 0.00
Emmaus Life Sciences (EMMA) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Verastem (VSTM) United States $0.099B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.097B 0.00
Aduro Biotech (ADRO) United States $0.095B 0.00
ARAVIVE, INC (ARAV) United States $0.094B 0.00
Arbutus Biopharma (ABUS) Canada $0.094B 0.00
OvaScience (MLND) United States $0.092B 0.00
Trevena (TRVN) United States $0.090B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.087B 0.00
VTv Therapeutics (VTVT) United States $0.085B 0.00
Mersana Therapeutics (MRSN) United States $0.084B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Checkpoint Therapeutics (CKPT) United States $0.082B 0.00
Curis (CRIS) United States $0.081B 0.00
Selecta Biosciences (SELB) United States $0.081B 0.00
Idera Pharmaceuticals (IDRA) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.078B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Liquidia Technologies (LQDA) United States $0.075B 0.00
Catalyst Biosciences (CBIO) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Pluristem Therapeutics (PSTI) Israel $0.064B 0.00
Applied Genetic Technologies (AGTC) United States $0.062B 34.20
AquaBounty Technologies (AQB) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.058B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.057B 0.00
Unum Therapeutics (UMRX) United States $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Stellar Biotechnologies (EDSA) Canada $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.050B 0.00
VBI Vaccines (VBIV) United States $0.049B 0.00
Oncobiologics (OTLK) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Ophthotech (ISEE) United States $0.047B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.043B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.036B 0.00
BIOCARDIA INC (BCDA) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
Caladrius Biosciences (CLBS) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Clearside Biomedical (CLSD) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Soligenix (SNGX) United States $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
TOCAGEN INC (TOCA) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Bionano Genomics (BNGO) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00